Investigating the trajectory of post-COVID impairments: a longitudinal study in SwedenShow others and affiliations
2024 (English)In: Frontiers in Psychology, E-ISSN 1664-1078, Vol. 15, article id 1402750
Article in journal (Refereed) Published
Abstract [en]
Introduction: Individuals recovering from COVID-19 often experience a range of post-recovery symptoms. However, the literature on post-COVID-19 symptoms reveals conflicting results, necessitating a heightened focus on longitudinal studies to comprehend the trajectory of impairments over time. Our study aimed to investigate changes in long-term impairments among individuals infected with COVID-19 and explore potential predictors influencing these changes. Methods: We conducted a web-survey targeting individuals that had been infected with COVID-19 at four time-points: T0 (baseline), T1 (three months), T2 (six months), and T3 (twelve months). The survey included contextual factors, factors related to body functions and structures, and post-COVID impairments. The longitudinal sample included 213 individuals (with a mean age of 48.92 years). Linear mixed models were employed to analyze changes in post-COVID impairments over time and identify impacting factors. Results: Findings revealed a general decline in post-COVID impairments over time, with each symptom exhibiting a dynamic pattern of fluctuations. Factors such as initial infection severity, education level, and work status were significantly associated with the levels of impairments. Discussion: The study emphasizes that post-COVID impairments are not static but exhibit variations over time. Personalized care, especially for vulnerable populations, is crucial. The results underscore the need for long-term monitoring and multidisciplinary treatment approaches. Targeted support and interventions are highlighted for individuals with severe initial infections and those in socioeconomically disadvantaged groups.
Place, publisher, year, edition, pages
Frontiers Media SA , 2024. Vol. 15, article id 1402750
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:ri:diva-74905DOI: 10.3389/fpsyg.2024.1402750Scopus ID: 2-s2.0-85196761885OAI: oai:DiVA.org:ri-74905DiVA, id: diva2:1892477
Note
The study was financed by grants from the Swedish state under the ALF agreement between the Swedish government and the county councils (Grant No. ALFGBG-983604).
2024-08-272024-08-272025-09-23Bibliographically approved